Cited 44 times in
Adiponectin receptor-mediated signaling ameliorates cerebral cell damage and regulates the neurogenesis of neural stem cells at high glucose concentrations: an in vivo and in vitro study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김어수 | - |
dc.contributor.author | 김철훈 | - |
dc.contributor.author | 송주현 | - |
dc.contributor.author | 송호택 | - |
dc.contributor.author | 이종은 | - |
dc.date.accessioned | 2016-02-04T11:36:17Z | - |
dc.date.available | 2016-02-04T11:36:17Z | - |
dc.date.issued | 2015 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/140792 | - |
dc.description.abstract | In the central nervous system (CNS), hyperglycemia leads to neuronal damage and cognitive decline. Recent research has focused on revealing alterations in the brain in hyperglycemia and finding therapeutic solutions for alleviating the hyperglycemia-induced cognitive dysfunction. Adiponectin is a protein hormone with a major regulatory role in diabetes and obesity; however, its role in the CNS has not been studied yet. Although the presence of adiponectin receptors has been reported in the CNS, adiponectin receptor-mediated signaling in the CNS has not been investigated. In the present study, we investigated adiponectin receptor (AdipoR)-mediated signaling in vivo using a high-fat diet and in vitro using neural stem cells (NSCs). We showed that AdipoR1 protects cell damage and synaptic dysfunction in the mouse brain in hyperglycemia. At high glucose concentrations in vitro, AdipoR1 regulated the survival of NSCs through the p53/p21 pathway and the proliferation- and differentiation-related factors of NSCs via tailless (TLX). Hence, we suggest that further investigations are necessary to understand the cerebral AdipoR1-mediated signaling in hyperglycemic conditions, because the modulation of AdipoR1 might alleviate hyperglycemia-induced neuropathogenesis | - |
dc.description.statementOfResponsibility | open | - |
dc.format | application/pdf | - |
dc.relation.isPartOf | CELL DEATH & DISEASE | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Animals | - |
dc.subject.MESH | Cell Differentiation | - |
dc.subject.MESH | Cell Proliferation | - |
dc.subject.MESH | Cell Survival | - |
dc.subject.MESH | Cerebral Cortex/drug effects | - |
dc.subject.MESH | Cerebral Cortex/metabolism | - |
dc.subject.MESH | Cerebral Cortex/pathology | - |
dc.subject.MESH | Cyclin-Dependent Kinase Inhibitor p21/genetics* | - |
dc.subject.MESH | Cyclin-Dependent Kinase Inhibitor p21/metabolism | - |
dc.subject.MESH | Diet, High-Fat/adverse effects | - |
dc.subject.MESH | Gene Expression Regulation | - |
dc.subject.MESH | Glucose/toxicity* | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Hyperglycemia/etiology | - |
dc.subject.MESH | Hyperglycemia/genetics* | - |
dc.subject.MESH | Hyperglycemia/metabolism | - |
dc.subject.MESH | Hyperglycemia/pathology | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Mice | - |
dc.subject.MESH | Mice, Inbred C57BL | - |
dc.subject.MESH | Neural Stem Cells | - |
dc.subject.MESH | Neurogenesis/drug effects | - |
dc.subject.MESH | Neurogenesis/genetics | - |
dc.subject.MESH | Primary Cell Culture | - |
dc.subject.MESH | Receptors, Adiponectin/genetics* | - |
dc.subject.MESH | Receptors, Adiponectin/metabolism | - |
dc.subject.MESH | Receptors, Cytoplasmic and Nuclear/genetics* | - |
dc.subject.MESH | Receptors, Cytoplasmic and Nuclear/metabolism | - |
dc.subject.MESH | Signal Transduction | - |
dc.subject.MESH | Synapses/drug effects | - |
dc.subject.MESH | Synapses/metabolism | - |
dc.subject.MESH | Synapses/pathology | - |
dc.subject.MESH | Tumor Suppressor Protein p53/genetics* | - |
dc.subject.MESH | Tumor Suppressor Protein p53/metabolism | - |
dc.title | Adiponectin receptor-mediated signaling ameliorates cerebral cell damage and regulates the neurogenesis of neural stem cells at high glucose concentrations: an in vivo and in vitro study | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Psychiatry (정신과학) | - |
dc.contributor.googleauthor | J Song | - |
dc.contributor.googleauthor | SM Kang | - |
dc.contributor.googleauthor | E Kim | - |
dc.contributor.googleauthor | C-H Kim | - |
dc.contributor.googleauthor | H-T Song | - |
dc.contributor.googleauthor | JE Lee | - |
dc.identifier.doi | 10.1038/cddis.2015.220 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A00686 | - |
dc.contributor.localId | A01057 | - |
dc.contributor.localId | A02063 | - |
dc.contributor.localId | A02080 | - |
dc.contributor.localId | A03146 | - |
dc.relation.journalcode | J00482 | - |
dc.identifier.eissn | 2041-4889 | - |
dc.identifier.pmid | 26247729 | - |
dc.contributor.alternativeName | Kim, Eo Su | - |
dc.contributor.alternativeName | Kim, Chul Hoon | - |
dc.contributor.alternativeName | Song, Ju Hyun | - |
dc.contributor.alternativeName | Song, Ho Taek | - |
dc.contributor.alternativeName | Lee, Jong Eun | - |
dc.contributor.affiliatedAuthor | Kim, Eo Su | - |
dc.contributor.affiliatedAuthor | Kim, Chul Hoon | - |
dc.contributor.affiliatedAuthor | Song, Ju Hyun | - |
dc.contributor.affiliatedAuthor | Song, Ho Taek | - |
dc.contributor.affiliatedAuthor | Lee, Jong Eun | - |
dc.rights.accessRights | free | - |
dc.citation.volume | 6 | - |
dc.citation.startPage | 1844 | - |
dc.identifier.bibliographicCitation | CELL DEATH & DISEASE, Vol.6 : 1844, 2015 | - |
dc.identifier.rimsid | 30316 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.